CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL) .2. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE

被引:21
作者
WEXLER, J
EAGLE, H
TATUM, HJ
MAGNUSON, HJ
WATSON, EB
机构
关键词
D O I
10.1172/JCI101729
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:467 / 473
页数:7
相关论文
共 8 条
[1]   CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL) .1. THE SYSTEMIC TREATMENT OF EXPERIMENTAL ARSENIC POISONING (MAPHARSEN, LEWISITE, PHENYL ARSENOXIDE) WITH BAL [J].
EAGLE, H ;
MAGNUSON, HJ ;
FLEISCHMAN, R .
JOURNAL OF CLINICAL INVESTIGATION, 1946, 25 (04) :451-466
[2]  
EAGLE H, AM J SYPH
[3]  
EAGLE H, 1944, UNPUB
[4]   CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL) .8. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION [J].
LUETSCHER, JA ;
EAGLE, H ;
LONGCOPE, WT .
JOURNAL OF CLINICAL INVESTIGATION, 1946, 25 (04) :534-540
[5]  
Magnuson H. J., 1944, INDUST AND ENGINEER CHEM ANALYT ED, V16, P339, DOI 10.1021/i560129a026
[6]  
RIKER WF, 1944, UNPUB
[7]   CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL) .3. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION [J].
SULZBERGER, MB ;
BAER, RL ;
KANOF, A .
JOURNAL OF CLINICAL INVESTIGATION, 1946, 25 (04) :474-479
[8]   BAL (BRITISH ANTI-LEWISITE) [J].
WATERS, LL ;
STOCK, C .
SCIENCE, 1945, 102 (2659) :601-606